| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454609 | Lung Cancer | 2016 | 6 Pages |
Abstract
There was no evidence that metformin improved survival among people with type 2 diabetes and pleural mesothelioma or to support trials of metformin in people with mesothelioma.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hongjiang Wu, Jeremy Walker, Ronald A. Damhuis, David H. Brewster, Sarah H. Wild, the Scottish Diabetes Research Network Epidemiology Group the Scottish Diabetes Research Network Epidemiology Group,